GO:1903143 adrenomedullin receptor complex: Components, Assembly and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:1903143 (adrenomedullin receptor complex) is a transmembrane, G protein-coupled signaling receptor complex capable of adrenomedullin receptor activity.
• The complex is formed by the calcitonin receptor-like receptor (CLR) paired with a receptor activity-modifying protein (RAMP), most commonly RAMP2 for AM1 and RAMP3 for AM2 [2,4].
• Adrenomedullin (ADM) and adrenomedullin 2/intermedin (ADM2) are the principal peptide ligands that activate the complex [2,3].
• The complex signals through Gs-mediated cAMP elevation and participates in vasodilation, cardioprotection, lymphatic development, and neuroblastoma biology [6,7,8].
• Dysregulation of the adrenomedullin receptor complex is implicated in cardiovascular disease, sepsis, cancer, and neuroblastoma [1,6,8].
• CRISPR knockout, point-mutation, knock-in, and overexpression models enable precise interrogation of CLR, RAMP2, RAMP3, ADM, and ADM2 in disease-relevant cells.
Description
The adrenomedullin receptor complex (GO:1903143) is a transmembrane, G protein-coupled signaling receptor complex that is capable of adrenomedullin receptor activity. It is the molecular entity through which the peptide hormone adrenomedullin (ADM) and the related peptide adrenomedullin 2/intermedin (ADM2) transmit signals across the plasma membrane [2,3]. The complex is not a single polypeptide but a heteromeric assembly of the calcitonin receptor-like receptor (CLR) and a receptor activity-modifying protein (RAMP), most commonly RAMP2 or RAMP3 [2,4]. This heterodimer is the functional unit that binds adrenomedullin and initiates downstream signaling [2,4]. Researchers study GO:1903143 because it sits at the intersection of cardiovascular physiology, lymphatic biology, and cancer. The complex mediates vasodilation and cardioprotection [6,7], contributes to lymphatic endothelial junctional remodeling, and has been linked to neuroblastoma peptidergic systems. In critical illness such as sepsis, adrenomedullin and its receptor complex are recognized as important mediators of vascular tone and endothelial barrier function. Understanding the assembly, ligand specificity, and downstream signaling of this complex is therefore essential for both basic vascular biology and translational medicine. From a methodological standpoint, the adrenomedullin receptor complex is an attractive target for CRISPR-based functional genomics. Because the complex requires coordinated expression of CLR and a RAMP, knockout of either subunit abolishes signaling, while point mutations can dissect ligand-binding versus G protein-coupling interfaces [2,4]. Knock-in of tagged subunits and overexpression of wild-type or mutant receptors allow precise mapping of complex composition and trafficking. This article summarizes the authoritative GO definition, the core components, the molecular mechanism, disease relevance, and the experimental models used to study GO:1903143.
adrenomedullin receptor complex At A Glance
| GO ID | GO:1903143 |
|---|---|
| GO term | adrenomedullin receptor complex |
| Ontology | cellular_component |
| Synonym | adrenomedullin receptor AM1 complex; adrenomedullin receptor AM2 complex |
| Definition | A transmembrane, G protein-coupled signaling receptor complex which is capable of adrenomedullin receptor activity. |
| Major function | Binds adrenomedullin and adrenomedullin 2/intermedin to activate G protein-coupled signaling, principally cAMP elevation [2,3]. |
| Core subunits | Calcitonin receptor-like receptor (CLR) and a receptor activity-modifying protein (RAMP2 or RAMP3) [2,4]. |
| Primary ligands | Adrenomedullin (ADM) and adrenomedullin 2/intermedin (ADM2) [2,3]. |
| Tissue context | Vascular endothelial cells, vascular smooth muscle cells, lymphatic endothelium, and neuroblastoma [4,5,8]. |
What Is GO:1903143?
GO:1903143 (adrenomedullin receptor complex) is defined in the Gene Ontology as a transmembrane, G protein-coupled signaling receptor complex which is capable of adrenomedullin receptor activity. In practical terms, it is a heteromeric receptor assembly in which the calcitonin receptor-like receptor (CLR) is paired with a receptor activity-modifying protein (RAMP), most often RAMP2 or RAMP3, to form a functional binding site for adrenomedullin and related peptides [2,4]. The complex spans the plasma membrane and couples to heterotrimeric G proteins to initiate intracellular signaling [2,7].
Why Is adrenomedullin receptor complex Important in Cell Biology?
The adrenomedullin receptor complex is important because it is the primary signaling gateway for adrenomedullin and adrenomedullin 2, two peptides with broad cardiovascular, lymphatic, and neuroendocrine actions [2,6]. Its activity influences vascular tone, endothelial barrier function, and cardioprotection, making it a focal point in sepsis and cardiovascular research [1,6,7]. In cancer, particularly neuroblastoma, peptidergic systems including adrenomedullin signaling are being explored as disease-relevant pathways. Because the complex is a heterodimer of CLR and a RAMP, its function is exquisitely dependent on subunit stoichiometry and trafficking, which makes it an excellent model for studying G protein-coupled receptor assembly and pharmacology [2,4].
• Mediates adrenomedullin-induced vasodilation and cardiovascular homeostasis [6,7].
• Contributes to endothelial barrier regulation and vascular permeability in critical illness such as sepsis.
• Participates in lymphatic endothelial junctional remodeling and reelin secretion.
• Is implicated in neuroblastoma peptidergic signaling and tumor biology.
• Provides a paradigm for heteromeric G protein-coupled receptor assembly with RAMPs [2,4].
• Serves as a pharmacological target for adrenomedullin-based cardioprotection.
• Enables dissection of ligand specificity between AM1 (CLR/RAMP2) and AM2 (CLR/RAMP3) complexes [2,3].
• Supports CRISPR functional genomics of CLR, RAMP2, RAMP3, ADM, and ADM2 in disease models [4,8].
Structure, Assembly and Molecular Mechanism of the adrenomedullin receptor complex
Ligand recognition and receptor activation
In simple terms: Adrenomedullin binds to a receptor made of two different proteins, and this binding switches the receptor on.
Adrenomedullin (ADM) and adrenomedullin 2/intermedin (ADM2) are the principal peptide ligands for the adrenomedullin receptor complex [2,3]. The complex is a heteromer of the calcitonin receptor-like receptor (CLR) and a receptor activity-modifying protein (RAMP), with CLR/RAMP2 forming the AM1 complex and CLR/RAMP3 forming the AM2 complex [2,4]. Ligand binding to the extracellular face of this heteromer induces conformational changes that activate the associated G protein [2,7].
G protein coupling and cAMP signaling
In simple terms: Once activated, the receptor turns on a G protein that raises cAMP inside the cell.
The adrenomedullin receptor complex is a G protein-coupled signaling receptor complex. Activation by adrenomedullin leads to Gs-mediated stimulation of adenylyl cyclase and elevation of intracellular cAMP, which is a hallmark of adrenomedullin receptor activity [2,7]. This cAMP signal is the primary intracellular readout used to monitor complex function in endothelial and vascular smooth muscle cells.
Subunit composition: CLR and RAMP2/RAMP3
In simple terms: The receptor is built from a large signaling protein plus a small helper protein that decides which ligand it prefers.
The calcitonin receptor-like receptor (CLR) is the core seven-transmembrane subunit, while receptor activity-modifying proteins (RAMPs) are accessory subunits that chaperone CLR to the cell surface and define ligand selectivity [2,4]. The RAMP2/CLR complex is a functional adrenomedullin receptor in human endothelial and vascular smooth muscle cells. In Xenopus tropicalis, adrenomedullin 2 and adrenomedullin 5 activate the CLR-RAMP3 receptor complex, illustrating evolutionary conservation of RAMP-dependent pharmacology.
Assembly and trafficking of the heteromer
In simple terms: The two receptor proteins must find each other and travel to the cell surface together to work.
RAMP proteins act as chaperones that facilitate CLR maturation and transport to the plasma membrane, where the heteromer is presented as a functional adrenomedullin receptor complex [2,4]. Proximity interactome studies of lymphatic VE-cadherin have revealed mechanisms of junctional remodeling and reelin secretion that involve adrenomedullin receptor complex components in endothelial cells. Correct assembly and surface expression are therefore prerequisites for adrenomedullin responsiveness [2,5].
Receptor regulation and desensitization
In simple terms: After signaling, the receptor is turned down or recycled so the cell does not stay switched on forever.
Like other G protein-coupled receptors, the adrenomedullin receptor complex is subject to regulatory mechanisms that tune its responsiveness, including receptor internalization and downstream feedback [2,7]. The balance between CLR and RAMP expression levels influences the amount of functional complex at the cell surface and thus the magnitude of adrenomedullin signaling [2,4]. This regulation is relevant to cardiovascular and lymphatic physiology where adrenomedullin tone must be dynamically controlled [6,7].
Key Genes Involved in GO:1903143 adrenomedullin receptor complex
The adrenomedullin receptor complex is built from a defined set of genes encoding the receptor subunits, their chaperones, and the peptide ligands that activate the complex.
| Gene | Major Role | Research Relevance |
|---|---|---|
| ADM | Encodes adrenomedullin, the primary peptide ligand | Central to cardiovascular and sepsis research [1,6] |
| ADM2 | Encodes adrenomedullin 2/intermedin, an alternative ligand | Ligand specificity studies for AM2 complex |
| CALCRL | Encodes the calcitonin receptor-like receptor (CLR), the core seven-transmembrane subunit | Essential for adrenomedullin receptor activity [2,4] |
| RAMP2 | Encodes receptor activity-modifying protein 2, defining the AM1 complex | Forms functional adrenomedullin receptor with CLR in endothelial cells |
| RAMP3 | Encodes receptor activity-modifying protein 3, defining the AM2 complex | Mediates adrenomedullin 2 and adrenomedullin 5 signaling |
| CRCP | Calcitonin receptor component protein, supports receptor function | Accessory factor in calcitonin/CLR signaling |
| GNAS | Encodes Gs alpha subunit coupling to cAMP | Downstream effector of adrenomedullin receptor complex [2,7] |
| ADCY | Adenylyl cyclase family generating cAMP | Readout of adrenomedullin receptor activation [2,7] |
| CDH5 | VE-cadherin, lymphatic endothelial junctional protein | Interactome links to adrenomedullin receptor complex in lymphatics |
| RELN | Reelin, secreted protein in junctional remodeling | Linked to adrenomedullin receptor complex interactome |
| NGF | Neurotrophic factor in peptidergic systems | Context for neuroblastoma peptidergic signaling |
| BDNF | Neurotrophin in peptidergic systems | Context for neuroblastoma peptidergic signaling |
| TH | Tyrosine hydroxylase, catecholamine synthesis | Neuroblastoma differentiation context |
| MYCN | Neuroblastoma oncogene | Disease context for adrenomedullin pathway |
| VEGFA | Vascular endothelial growth factor A | Angiogenesis context with adrenomedullin |
| NOS3 | Endothelial nitric oxide synthase | Vasodilation downstream of adrenomedullin [6,7] |
| EDN1 | Endothelin 1, opposing vascular peptide | Vascular tone balance with adrenomedullin |
How Is adrenomedullin receptor complex Regulated?
The adrenomedullin receptor complex is regulated at multiple levels. Expression of the core subunit CLR and the accessory RAMPs determines the amount of functional heteromer at the cell surface, and RAMP availability is a key determinant of ligand selectivity [2,4]. Receptor activity is also tuned by G protein-coupled receptor regulatory mechanisms such as internalization and desensitization, which modulate the duration and amplitude of cAMP signaling [2,7]. In pathophysiological states such as sepsis and cardiovascular stress, adrenomedullin levels and receptor complex activity are dynamically altered, reflecting the complex's role in vascular tone and endothelial barrier regulation [1,6,7].
adrenomedullin receptor complex and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| ADM | Sepsis and cardiovascular disease | Endothelial cell knockout and overexpression [1,6] |
| CALCRL | Vascular dysfunction | CRISPR knockout in vascular smooth muscle cells |
| RAMP2 | Endothelial barrier and lymphatic biology | Knockout and tagged knock-in in endothelial cells [4,5] |
| RAMP3 | Ligand selectivity and AM2 signaling | Point mutation and knock-in in Xenopus and mammalian cells |
| MYCN | Neuroblastoma | Overexpression and knockout in neuroblastoma cell lines |
Cardiovascular disease and cardioprotection
Adrenomedullin and its receptor complex are recognized for cardioprotective actions, including vasodilation and protection against cardiac injury. The complex is a continuing focus of exploration for therapeutic modulation in cardiovascular disease. Circulation control by the adrenomedullin 1 receptor complex further supports its central role in vascular regulation.
Sepsis and critical illness
In critical illness such as sepsis, adrenomedullin signaling through its receptor complex contributes to vascular tone and endothelial barrier regulation, making it a biomarker and mechanistic player in intensive care medicine. Dysregulation of this pathway can contribute to hemodynamic instability.
Neuroblastoma and peptidergic systems
Peptidergic systems, including adrenomedullin-related signaling, are being investigated in neuroblastoma biology. The adrenomedullin receptor complex may influence tumor cell behavior through autocrine or paracrine peptide signaling.
Lymphatic biology and junctional remodeling
Proximity interactome studies of lymphatic VE-cadherin have linked adrenomedullin receptor complex components to mechanisms of junctional remodeling and reelin secretion in lymphatic endothelium. This positions the complex in lymphatic development and barrier function.
From adrenomedullin receptor complex-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does CLR loss abolish adrenomedullin signaling? | CALCRL knockout cell line [2,4] |
| Which RAMP defines AM1 versus AM2 pharmacology? | RAMP2 or RAMP3 knockout and rescue [3,4] |
| Which residues mediate ligand binding? | Point-mutation knock-in of CLR or RAMP |
| Where is the complex localized in endothelium? | Tagged knock-in of CLR or RAMP2 |
| Does adrenomedullin overexpression alter vascular tone? | ADM overexpression in endothelial cells |
| Can receptor complex activity be monitored by cAMP? | Overexpression of wild-type and mutant complex with cAMP reporter [2,7] |
How to Study the adrenomedullin receptor complex Process
| Method | What It Measures | Typical Application |
|---|---|---|
| CRISPR knockout | Loss of receptor subunit function | Testing requirement for adrenomedullin signaling [2,4] |
| Point mutation | Specific residue contribution to binding or coupling | Structure-function dissection of CLR/RAMP |
| Tagged knock-in | Subcellular localization and trafficking | Visualizing complex assembly in endothelium |
| cAMP assay | G protein-coupled signaling output | Quantifying adrenomedullin receptor activity [2,7] |
| Proximity interactome | Protein-protein interactions | Mapping complex partners in lymphatics |
| RNA-seq | Transcriptional consequences of complex activation | Downstream pathway discovery |
| Overexpression | Gain-of-function signaling | Testing ligand specificity and receptor output [3,6] |
| Immunofluorescence | Tissue and cellular distribution | Localizing complex in vascular tissue [4,5] |
CRISPR knockout and functional genomics
CRISPR knockout of CALCRL, RAMP2, or RAMP3 is used to test whether the adrenomedullin receptor complex is required for ligand-induced cAMP signaling and downstream vascular or lymphatic phenotypes [2,4]. Loss-of-function models help distinguish the contributions of AM1 versus AM2 complexes [3,4].
Point-mutation and knock-in approaches
Point mutations in CLR or RAMP subunits can dissect ligand-binding interfaces from G protein-coupling domains, while tagged knock-in enables visualization of complex trafficking and localization [2,5]. These approaches are essential for mapping structure-function relationships in the heteromer.
Proximity interactome and proteomics
Proximity interactome studies of lymphatic VE-cadherin have revealed mechanisms of junctional remodeling and reelin secretion involving adrenomedullin receptor complex components, demonstrating the value of proteomic mapping for this complex.
cAMP signaling assays and imaging
Because adrenomedullin receptor activity is coupled to cAMP elevation, cAMP reporters and imaging are standard readouts for complex function in endothelial and vascular smooth muscle cells [2,4,7]. These assays can be combined with CRISPR models to quantify signaling strength [2,7].
How CRISPR Can Be Used to Study GO:1903143 adrenomedullin receptor complex
Knockout
CRISPR knockout of CALCRL, RAMP2, or RAMP3 abolishes formation of the adrenomedullin receptor complex and eliminates adrenomedullin-induced cAMP signaling, providing a clean loss-of-function platform to test causality in vascular and lymphatic phenotypes [2,4].
Point Mutation
Point mutations introduced into CLR or RAMP genes allow precise dissection of ligand-binding versus G protein-coupling interfaces, helping to define the molecular determinants of adrenomedullin receptor activity.
Knock-in
Tagged knock-in of CLR or RAMP subunits enables tracking of complex assembly, trafficking, and localization in endothelial cells, complementing proximity interactome studies of junctional remodeling.
Overexpression
Overexpression of wild-type or mutant adrenomedullin receptor complex components, or of the ligands ADM and ADM2, is used to probe gain-of-function signaling, ligand selectivity, and cardioprotective or neuroblastoma-relevant phenotypes [3,6,8].
How EDITGENE Supports adrenomedullin receptor complex Research
Researchers studying adrenomedullin receptor complex-related genes often need to determine whether a candidate gene is causally involved in receptor assembly, ligand recognition, or downstream signaling. EDITGENE provides the CRISPR tools and cell models needed to move from correlation to causation in this heteromeric G protein-coupled receptor system.
Contact EDITGENE today to design your custom CRISPR model for adrenomedullin receptor complex research.
Frequently Asked Questions About adrenomedullin receptor complex
What is the adrenomedullin receptor complex?
It is a transmembrane, G protein-coupled signaling receptor complex capable of adrenomedullin receptor activity, defined as GO:1903143.
What genes are involved in the adrenomedullin receptor complex?
The core genes are CALCRL, which encodes CLR, and RAMP2 or RAMP3, which encode the accessory receptor activity-modifying proteins [2,4].
What is the difference between AM1 and AM2 adrenomedullin receptor complexes?
AM1 is formed by CLR with RAMP2, while AM2 is formed by CLR with RAMP3, and these complexes differ in ligand selectivity [2,3].
Which ligands activate the adrenomedullin receptor complex?
Adrenomedullin (ADM) and adrenomedullin 2/intermedin (ADM2) are the principal activating peptides [2,3].
What signaling pathway does the adrenomedullin receptor complex use?
It couples to Gs and elevates intracellular cAMP, which is the primary signaling readout [2,7].
Is the adrenomedullin receptor complex involved in cardiovascular disease?
Yes, it mediates vasodilation and cardioprotective actions and is studied in cardiovascular disease and sepsis [1,6,7].
How is the adrenomedullin receptor complex studied with CRISPR?
CRISPR knockout of CALCRL, RAMP2, or RAMP3 abolishes complex function, while point mutations and knock-in dissect mechanism [2,4,5].
What diseases are linked to adrenomedullin receptor complex dysfunction?
Cardiovascular disease, sepsis, lymphatic dysfunction, and neuroblastoma have been linked to this pathway [1,5,6,8].
Where is the adrenomedullin receptor complex expressed?
It is expressed in vascular endothelial cells, vascular smooth muscle cells, and lymphatic endothelium [4,5].
Can EDITGENE create custom models for adrenomedullin receptor complex research?
Yes, EDITGENE offers knockout, point-mutation, knock-in, overexpression, library screening, and bioinformatics services for this pathway [2,4,5].
Conclusion
The adrenomedullin receptor complex (GO:1903143) is a heteromeric G protein-coupled receptor assembly that serves as the primary signaling gateway for adrenomedullin and adrenomedullin 2. Its core subunits, CLR and RAMP2/RAMP3, define ligand specificity and couple to cAMP signaling, with important roles in cardiovascular, lymphatic, and neuroblastoma biology [2,3,4,5,6,8]. CRISPR-based knockout, point-mutation, knock-in, and overexpression models provide the precision needed to dissect this complex in health and disease. EDITGENE's integrated cell model and screening services support researchers seeking to move from candidate gene to causal mechanism in adrenomedullin receptor complex biology.
References
- 1. Bateman RM et al.. 2016. 36th International Symposium on Intensive Care and Emergency Medicine : Brussels, Belgium. 15-18 March 2016.. Crit Care 20(Suppl 2):94 PMID: 27885969
- 2. Smith DM et al.. 2002. Adrenomedullin: receptor and signal transduction.. Biochem Soc Trans 30(4):432-7 PMID: 12196109
- 3. Ogoshi M et al.. 2021. Adrenomedullin 2 and 5 activate the calcitonin receptor-like receptor (clr) - Receptor activity-modifying protein 3 (ramp3) receptor complex in Xenopus tropicalis.. Gen Comp Endocrinol 306:113752 PMID: 33711314
- 4. Kamitani S et al.. 1999. The RAMP2/CRLR complex is a functional adrenomedullin receptor in human endothelial and vascular smooth muscle cells.. FEBS Lett 448(1):111-4 PMID: 10217420
- 5. Serafin DS et al.. 2024. Proximity interactome of lymphatic VE-cadherin reveals mechanisms of junctional remodeling and reelin secretion.. Nat Commun 15(1):7734 PMID: 39232006
- 6. Tsuruda T et al.. 2019. Adrenomedullin: Continuing to explore cardioprotection.. Peptides 111:47-54 PMID: 29577955
- 7. Kuwasako K et al.. 2012. [Circulation control by adrenomedullin 1 receptor complex].. Nihon Yakurigaku Zasshi 140(1):8-13 PMID: 22790226
- 8. Sánchez ML et al.. 2025. Peptidergic Systems and Neuroblastoma.. Int J Mol Sci 26(8) PMID: 40331938
